Precision medicine, genomics and immunotherapies at ASH 2017
How is the landscape of Hodgkin lymphoma therapy changing?
Frontline therapy and the role of high-dose consolidation in mantle cell lymphoma
COMy 2017: Day 2 discussion on relapsed myeloma, treatment, plasma cell leukemia and awards
Arnon Nagler et al.
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?